Stock listing
Corvus Pharmaceuticals, Inc.
- Ticker
- Dusseldorf:C17
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Dusseldorf
- Currency
- EUR
About Corvus Pharmaceuticals, Inc.
Corvus Pharmaceuticals, Inc. (Ticker: CRVS) is a publicly traded company based in the United States, focusing on the development of innovative therapies for cancer treatment. The company is committed to addressing unmet medical needs through its unique approach to drug development.
Latest news from Corvus Pharmaceuticals, Inc.
Corvus Pharmaceuticals Announces Initiation of Phase 1b Clinical Trial of Soquelitinib for Patients with Hidradenitis Suppurativa
Sep 30, 2026
Corvus Pharmaceuticals to Present at the 2026 Cantor Global Healthcare Conference
Sep 3, 2026
Corvus Pharmaceuticals Announces Publication in Blood of Final Phase 1 Data from the Soquelitinib Phase 1/1b T Cell Lymphoma Trial
Aug 27, 2026
Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2026 Financial Results
Aug 6, 2026